The growing role of precision and personalized medicine for cancer treatment.
Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, White C, Lowe C, Sherba JJ, Hartmanshenn C, O'Neill KM, Balter ML, Fritz ZR, Androulakis IP, Schloss RS, Yarmush ML. · 2018
Read The growing role of precision and personalized medicine for cancer treatment. by Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, White C, Lowe C, Sherba JJ, Hartmanshenn C, O'Neill KM, Balter ML, Fritz ZR, Androulakis IP, Schloss RS, Yarmush ML. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6352312.txt.
Introduction
Krzyszczyk and co-authors survey precision and personalized medicine for cancer. Their review appeared in Technology. Standard chemotherapy and radiation help only some patients. Tumors differ in genes and proteins between people. That variety suits tailored treatment instead. Efforts now gather molecular data on many tumors.
Some products already match tumor traits to drugs. Patients can gain large benefits from such matches. Companies and regulators have begun to back the shift. Barriers remain in cost, data, and testing access. The review covers the tools that profile tumors. It also covers how those profiles guide care. The authors see tailored therapy as cancer care's direction. They stress that proof must keep pace with promise.
Catalog record
| CREATOR | Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, White C, Lowe C, Sherba JJ, Hartmanshenn C, O'Neill KM, Balter ML, Fritz ZR, Androulakis IP, Schloss RS, Yarmush ML. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 124 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |